0001415889-24-002936.txt : 20240207 0001415889-24-002936.hdr.sgml : 20240207 20240207163806 ACCESSION NUMBER: 0001415889-24-002936 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240206 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Savitz Adam CENTRAL INDEX KEY: 0002008707 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41944 FILM NUMBER: 24604863 MAIL ADDRESS: STREET 1: C/O ALTO NEUROSCIENCE, INC. STREET 2: 369 SOUTH SAN ANTONIO ROAD CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 form4-02072024_090257.xml X0508 4 2024-02-06 0001999480 Alto Neuroscience, Inc. ANRO 0002008707 Savitz Adam C/O ALTO NEUROSCIENCE, INC. 369 SOUTH SAN ANTONIO ROAD LOS ALTOS CA 94022 false true false false CHIEF MEDICAL OFFICER 0 Common Stock 2024-02-06 4 C 0 7851 A 7851 I By Trust Common Stock 2024-02-06 4 P 0 17000 16 A 24851 I By Trust Series B Preferred Stock 2024-02-06 4 C 0 16666 0 D Common Stock 7851 0 I By Trust Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date. The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust. /s/ Erin R. McQuade, Attorney-in-Fact 2024-02-07